Vertical gradients of lung density in supine subjects with fibrosing alveolitis or pulmonary emphysema

Millar, A B; Denison, D M
August 1990
Thorax;Aug1990, Vol. 45 Issue 8, p602
Academic Journal
No abstract available.


Related Articles

  • SCIENTIFIC FRONTIERS IN LUNG DISEASE.  // Thorax;Dec2001 Supp, Vol. 56, piii41 

    This article presents various studies related to scientific frontiers in lung disease. The immune pathology of sarcoidosis is characterized by an exaggerated CD4 T cell response to an undefined antigens. Spontaneous remission occurs in the majority of subjects, but 30% of patients develon...

  • Infectious mononucleosis and fibrosing alveolitis. Millar, J.W. // British Medical Journal;3/5/1977, Vol. 1 Issue 6061, p612 

    Reports on the case of infectious mononucleosis with acute diffuse fibrosing alveolitis. Presence of pulmonary lesions in the disease; Aetiology of acute fibrosing alveolitis; Implication of the Epstein-Barr virus.

  • Flying with interstitial fibrosis. G.A.L. // Cortlandt Forum;4/25/95, Vol. 8 Issue 4, p103 

    Replies to a question by physician Harry J. Corwin on whether it is alright for a woman with interstitial fibrosis at both lungs to travel by air. Tolerance of altitude; Slow progress of idiopathic pulmonary fibrosis (fibrosing alveolitis); Identification of the nature of the interstitial...

  • interstitial pulmonary fibrosis. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p431 

    A definition of the term "interstitial pulmonary fibrosis" (IPF) is presented. It refers to scarring of lung tissue mainly affecting the alveoli. The causes of IPF include occupational exposure to mineral dusts, an autoimmune disorder called fibrosing alveolitis and an allergic reaction leading...

  • Pulmonary Fibrosis.  // Current Medical Literature: Respiratory Medicine;2010, Vol. 24 Issue 1, p23 

    The article reviews several studies on pulmonary fibrosis. It cites an investigation on the effect of bosentan in patients with idiopathic pulmonary fibrosis (IPF) in the Bosentan Use in Interstitial Lung Disease-1 (BUILD-1) trial which note that endothelin antagonists do not have any proven...

  • Change in regional pulmonary perfusion as a result of posture and lung volume assessed using technetium-99m macroaggregated albumin single-photon emission tomography. Kosuda, Shigeru; Kobayashi, Hideo; Kusano, Shoichi // European Journal of Nuclear Medicine;2000, Vol. 27 Issue 5, p529 

    The purpose of this study was to evaluate the effects of gravity and lung volume on regional pulmonary perfusion using technetium-99m macroaggregated albumin (99mTc MAA) single-photon emission tomography (SPET). Twenty-five subjects were classified into three groups according to their position...

  • Volume adjustment of lung density by computed tomography scans in patients with emphysema. Shaker, S. B.; Dirksen, A.; Laursen, L. C.; Skovgaard, L. T.; Holstein-Rathlou, N.-H. // Acta Radiologica;Jul2004, Vol. 45 Issue 4, p417 

    Purpose: To determine how to adjust lung density measurements for the volume of the lung calculated from computed tomography (CT) scans in patients with emphysema. Material and Methods: Fifty patients with emphysema underwent 3 CT scans at 2-week intervals. The scans...

  • Pulmonary Infiltrates and Skin Pigmentation Associated with Sulfasalazine. Gabazza, Esteban C.; Taguchi, Osamu; Yamakami, Tomoya; Machishi, Motoko; Ibata, Hidenori; Suzuki, Shiro; Matsumoto, Koichi; Kitagawa, Tatsushi; Yamamoto, Junji // American Journal of Gastroenterology;Nov1992, Vol. 87 Issue 11, p1654 

    A patient with ulcerative colitis developed skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology, while taking sulfasalazine. The clinical picture and radiological abnormalities disappeared spontaneously on discontinuation of the drug. Histopathological studies...

  • Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab. Ostor, Andrew J. K.; Crisp, Adrian J.; Somerville, Margaret F.; Scott, David G. I. // BMJ: British Medical Journal (International Edition);11/27/2004, Vol. 329 Issue 7477, p1266 

    Presents a paper on fatal exacerbation of rheumatoid arthritis associated with fibrosing alveolitis in patients being treated with infliximab. Report on three cases of patients who suffered sudden onset breathlessness associated with deteriorating lung function after just a few doses of...

  • Infliximab.  // Reactions Weekly;12/12/2009, Issue 1282, p24 

    The article describes the case of a 63-year-old man with pre-existing diffuse infiltrative lung condition who experienced fibrosing alveolitis after taking infliximab for treating rheumatoid arthritis (RA). His medical history included pulmonary tuberculosis, RA and Gougerot-Sjögren syndrome...


Read the Article


Sign out of this library

Other Topics